Inflammatory markers changes following acceptance-based behavioral psychotherapy in generalized anxiety disorder patients: Evidence from a randomized controlled trial

abbtpapercliniciantier 3link ok

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This randomized controlled trial examines changes in peripheral inflammatory biomarkers among 77 patients with generalized anxiety disorder following a 14-week acceptance-based behavioral therapy (ABBT) program compared to supportive group therapy. The study reports that while IL-6 levels increased in the ABBT group and IL-1β decreased in the control group, there were no significant differences between groups for most markers, and no correlation was found between inflammatory changes and anxiety symptom reduction for most variables. The resource is intended for researchers or clinicians interested in the biological correlates of psychotherapy outcomes.

ID
f242d393fc09478d
Source org
PubMed Central
Author
Not recorded
Published
Not recorded
OA status
Not recorded
DOI
10.1016/j.bbih.2024.100779
PMID
Not recorded
PMCID
PMC3940006
Citations
Not recorded

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:f242d393fc09478d,
  title = {Inflammatory markers changes following acceptance-based behavioral psychotherapy in generalized anxiety disorder patients: Evidence from a randomized controlled trial},
  journal = {PubMed Central},
  doi = {10.1016/j.bbih.2024.100779},
  url = {https://doi.org/10.1016/j.bbih.2024.100779}
}

RIS

TY  - JOUR
TI  - Inflammatory markers changes following acceptance-based behavioral psychotherapy in generalized anxiety disorder patients: Evidence from a randomized controlled trial
PB  - PubMed Central
DO  - 10.1016/j.bbih.2024.100779
UR  - https://doi.org/10.1016/j.bbih.2024.100779
ER  - 

APA

Inflammatory markers changes following acceptance-based behavioral psychotherapy in generalized anxiety disorder patients: Evidence from a randomized controlled trial. (n.d.). PubMed Central. https://doi.org/10.1016/j.bbih.2024.100779

Related entries

More like this